ETF Managers Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | $46.6K | Buy |
18,339
+4,490
| +32% | +$11.4K | ﹤0.01% | 662 |
|
2022
Q4 | $25.9K | Sell |
13,849
-2,341
| -14% | -$4.38K | ﹤0.01% | 506 |
|
2022
Q3 | $42K | Sell |
16,190
-1,022
| -6% | -$2.65K | ﹤0.01% | 673 |
|
2022
Q2 | $35K | Buy |
17,212
+1,988
| +13% | +$4.04K | ﹤0.01% | 723 |
|
2022
Q1 | $45K | Buy |
15,224
+51
| +0.3% | +$151 | ﹤0.01% | 661 |
|
2021
Q4 | $68K | Sell |
15,173
-2,000
| -12% | -$8.96K | ﹤0.01% | 654 |
|
2021
Q3 | $85K | Buy |
17,173
+3,329
| +24% | +$16.5K | ﹤0.01% | 644 |
|
2021
Q2 | $94K | Sell |
13,844
-137
| -1% | -$930 | ﹤0.01% | 623 |
|
2021
Q1 | $96K | Sell |
13,981
-8,218
| -37% | -$56.4K | ﹤0.01% | 640 |
|
2020
Q4 | $138K | Sell |
22,199
-3,235
| -13% | -$20.1K | ﹤0.01% | 589 |
|
2020
Q3 | $140K | Buy |
25,434
+12,864
| +102% | +$70.8K | ﹤0.01% | 593 |
|
2020
Q2 | $64K | Buy |
+12,570
| New | +$64K | ﹤0.01% | 589 |
|